Balyasny Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8M Buy
1,518,170
+1,404,441
+1,235% +$12.8M 0.02% 604
2025
Q1
$904K Buy
+113,729
New +$904K ﹤0.01% 1390
2022
Q4
Sell
-33,794
Closed -$1.32M 2690
2022
Q3
$1.32M Sell
33,794
-301,872
-90% -$11.8M ﹤0.01% 1296
2022
Q2
$10.8M Buy
335,666
+316,390
+1,641% +$10.2M 0.04% 512
2022
Q1
$638K Buy
+19,276
New +$638K ﹤0.01% 1425
2021
Q4
Hold
0
2266
2021
Q3
Hold
0
2033
2020
Q4
Sell
-142,289
Closed -$8.7M 1434
2020
Q3
$8.7M Buy
+142,289
New +$8.7M 0.06% 366
2020
Q2
Sell
-19,038
Closed -$547K 1275
2020
Q1
$547K Sell
19,038
-133,467
-88% -$3.83M 0.01% 764
2019
Q4
$11M Buy
+152,505
New +$11M 0.07% 365
2019
Q1
Hold
0
1487
2018
Q4
Sell
-75,593
Closed -$10.7M 1534
2018
Q3
$10.7M Buy
75,593
+61,362
+431% +$8.67M 0.05% 394
2018
Q2
$2.23M Sell
14,231
-223,900
-94% -$35.1M 0.01% 743
2018
Q1
$38.4M Sell
238,131
-23,069
-9% -$3.72M 0.16% 162
2017
Q4
$43M Sell
261,200
-98,602
-27% -$16.2M 0.13% 169
2017
Q3
$22.4M Buy
359,802
+169,302
+89% +$10.5M 0.09% 258
2017
Q2
$15.2M Sell
190,500
-65,443
-26% -$5.21M 0.06% 346
2017
Q1
$18.2M Sell
255,943
-121,417
-32% -$8.63M 0.08% 274
2016
Q4
$19.3M Buy
377,360
+147,354
+64% +$7.52M 0.1% 245
2016
Q3
$10.6M Buy
230,006
+118,097
+106% +$5.44M 0.06% 370
2016
Q2
$3.37M Buy
+111,909
New +$3.37M 0.02% 469
2016
Q1
Sell
-26,250
Closed -$1.53M 1278
2015
Q4
$1.53M Buy
+26,250
New +$1.53M 0.01% 558